Top compounds associated with response to ARL13A


Feature Type Standardized
Nominal ANOVA
mRNA Lisitinib GDSC1000 pan-cancer AAC -0.082 0.01
mRNA avicin D CTRPv2 pan-cancer AAC 0.13 0.01
mRNA dabrafenib CTRPv2 pan-cancer AAC -0.11 0.02
mRNA Gemcitabine GDSC1000 pan-cancer AAC 0.079 0.02
mRNA FMK GDSC1000 pan-cancer AAC -0.082 0.02
mRNA KU-60019 CTRPv2 pan-cancer AAC -0.078 0.02
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.02
mRNA GDC-0449 GDSC1000 pan-cancer AAC 0.078 0.02
mRNA Docetaxel CTRPv2 pan-cancer AAC 0.1 0.03
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.04
Download CSV